These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 7881837
41. Immunogenetic heterogeneity of rheumatoid arthritis. Westedt ML, Breedveld FC, Schreuder GM, D'Amaro J, Cats A, de Vries RR. Ann Rheum Dis; 1986 Jul; 45(7):534-8. PubMed ID: 3488713 [Abstract] [Full Text] [Related]
42. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. van Zeben D, Hazes JM, Zwinderman AH, Cats A, Schreuder GM, D'Amaro J, Breedveld FC. Arthritis Rheum; 1991 Jul; 34(7):822-30. PubMed ID: 2059230 [Abstract] [Full Text] [Related]
43. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Yelamos J, Garcia-Lozano JR, Moreno I, Aguilera I, Gonzalez MF, Garcia A, Nuñez-Roldan A, Sanchez B. Arthritis Rheum; 1993 Jun; 36(6):811-4. PubMed ID: 8507223 [Abstract] [Full Text] [Related]
44. Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population. de Jongh BM, van Romunde LK, Valkenburg HA, de Lange GG, van Rood JJ. Ann Rheum Dis; 1984 Aug; 43(4):613-9. PubMed ID: 6433814 [Abstract] [Full Text] [Related]
45. Associations of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. Olsen NJ, Callahan LF, Brooks RH, Nance EP, Kaye JJ, Stastny P, Pincus T. Am J Med; 1988 Feb; 84(2):257-64. PubMed ID: 3261537 [Abstract] [Full Text] [Related]
46. Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients. Boki KA, Drosos AA, Tzioufas AG, Lanchbury JS, Panayi GS, Moutsopoulos HM. Ann Rheum Dis; 1993 Jul; 52(7):517-9. PubMed ID: 8102226 [Abstract] [Full Text] [Related]
48. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition. Pascual M, Nieto A, López-Nevot MA, Ramal L, Matarán L, Caballero A, Alonso A, Martín J, Zanelli E. Arthritis Rheum; 2001 Feb; 44(2):307-14. PubMed ID: 11229460 [Abstract] [Full Text] [Related]
50. Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. Fridkis-Hareli M, Rosloniec EF, Fugger L, Strominger JL. Hum Immunol; 2000 Jul; 61(7):640-50. PubMed ID: 10880734 [Abstract] [Full Text] [Related]
53. A possible association of HLA-DR beta 1*04 subtypes and rheumatoid arthritis of peptide binding region amino acids. Varga E, Samu G, Pokornyi G, Schmidt Z, Merétey K, Petri IB. Acta Microbiol Immunol Hung; 1996 Jul; 43(1):67-74. PubMed ID: 8806945 [Abstract] [Full Text] [Related]
54. Predominance of HLA-DRB1*0405 in Korean patients with rheumatoid arthritis. Kim HY, Kim TG, Park SH, Lee SH, Cho CS, Han H. Ann Rheum Dis; 1995 Dec; 54(12):988-90. PubMed ID: 8546532 [Abstract] [Full Text] [Related]
55. Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis. Laivoranta-Nyman S, Möttönen T, Luukkainen R, Hakala M, Yli-Kerttula U, Hannonen P, Tuokko J, Toivanen A, Ilonen J. Ann Rheum Dis; 2000 Mar; 59(3):173-7. PubMed ID: 10700424 [Abstract] [Full Text] [Related]
59. Study of association between HLA-DR4 and DR53 and autoantibody detection in rheumatoid arthritis. Zhou Y, Tan L, Que Q, Li H, Cai L, Cao L, Ye Q, Xiong J. J Immunoassay Immunochem; 2013 Mar; 34(2):126-33. PubMed ID: 23537298 [Abstract] [Full Text] [Related]